Top compounds associated with response to PSG2


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.04 0.3
mRNA erlotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.042 0.3
mRNA BRD-K03536150 CTRPv2 pan-cancer AAC -0.041 0.3
mRNA selumetinib:piperlongumine (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.039 0.3
mRNA Rapamycin gCSI pan-cancer AAC 0.063 0.3
mRNA GSK1059615 CTRPv2 pan-cancer AAC -0.05 0.3
mRNA BRD-K85133207 CTRPv2 pan-cancer AAC -0.04 0.3
mRNA GW843682X CTRPv2 pan-cancer AAC -0.038 0.3
mRNA BRD-K19103580 CTRPv2 pan-cancer AAC -0.04 0.3
mRNA QW-BI-011 CTRPv2 pan-cancer AAC -0.072 0.3
Download CSV